Evidence map›Paper›PMID 40699993›Full record

ArticleAnnals of African medicine2026

Type 2 Diabetes in Morocco: Toward a Precision Diabetology, from Pathogenesis to Treatment.

Ahmed Anas Guerboub, Jade Issouani, Ikhlass Lakssir, Hajar Srifi, Malak Riznat, Mohamed Malad, Mustapha Asfour, Abderrahaman Tadlaoui, Yassine Errahali

Abstract read
In one paragraph

Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed Anas GuerboubDepartment of Endocrinology and Diabetology, Faculty of Medicine and Pharmacy, Mohammed V Military Academic Hospital, Mohammed V University Souissi, Rabat, Morocco.
Jade Issouani
Ikhlass Lakssir
Hajar Srifi
Malak Riznat
Mohamed Malad
Mustapha Asfour
Abderrahaman Tadlaoui
Yassine Errahali

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe traditional classification of diabetes into types 1 and 2 does not reflect its heterogeneity in presentation, progression, treatment response, and complications.

methodsThis study explores a new classification based on five distinct subgroups to enhance understanding and management. Its applicability was tested in 1002 newly diagnosed Moroccan type 2 diabetes patients and compared with the Indian "WellGen" and Swedish "ANDIS" cohorts.

resultsNewly diagnosed Moroccan type 2 diabetics were mainly classified into four subgroups designated as: severe insulin deficiency diabetes (SIDD), severe insulin resistance diabetes (SIRD), mild obesity-related diabetes (MOD), and mild age-related diabetes (MARD). One thousand and two patients were included in our study with a sex ratio of 1. Patients were classified into the subgroups of MARD (42%), MOD (21%), and SIDD (19%), while SIRD was 14%. In our study, retinopathy and neuropathy were more prevalent in the SIDD subgroup, while nephropathy in the SIRD, while patients in the MARD group had a higher prevalence of cardiovascular complications.

conclusionsOur results provide useful clues as to the pathophysiological mechanisms and susceptibility to complications of type 2 diabetes in the Moroccan population, and suggest a need to review management strategies. Our results confirm the new diabetic subgroups proposed by similar studies, suggesting a possible generalization of this diabetes classification to Africa and the MENA region.

Indexed as

Diabetes Mellitus, Type 2AdultAgedFemaleHumansInsulin ResistanceMaleMiddle AgedMoroccoObesityPrevalenceClusterdiabète de type 2diabétologie de précisionMarocMoroccoprecision diabetologytype 2 diabetes

Identifiers

PMID40699993
PMCPMC13056275

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.